Inogen Appoints Mira Kirti Sahney to Board of Directors
Inogen, Inc. (NASDAQ: INGN), a leading medical technology firm specializing in innovative respiratory solutions, has made a significant leadership change by appointing Mira Kirti Sahney to its Board of Directors. This decision reflects the company's focus on enhancing its operations and maintaining its leadership in respiratory care.
Transition With Experienced Leadership
The board appointment will take effect on January 31, 2025, showcasing the company’s strategic move to strengthen its governance. Simultaneously, Tom West, who has been a valuable member of the board since April 2023, will retire on January 30, 2025. Chairperson Elizabeth Mora expressed her gratitude for Mr. West's contributions during his tenure, emphasizing the positive impact he has made in the organization.
Impact of Mira Sahney's Appointment
Mira Sahney brings a wealth of experience in the medical device sector, which will be invaluable to Inogen as it strives for accelerated growth and success. Ms. Sahney is currently a board member at Claria Medical and has held key leadership roles at prominent companies, including serving as President of the Pelvic Health Operating Unit at Medtronic (NYSE: MDT). Her multifaceted expertise will be instrumental as Inogen navigates the evolving healthcare landscape.
Background of Mira Sahney
Mira Sahney began her career in medical technology as a co-founder of Myomo, Inc. (NYSE: MYO), where she pioneered developments in wearable medical robotics aimed at treating neurological disorders. Her journey continued with leadership positions at Smith + Nephew (LON: SNN), where she managed significant business divisions, refining her skills in both technical and operational aspects of the industry.
Educational Credentials
Ms. Sahney’s academic credentials reinforce her suitability for the board role. She graduated summa cum laude from the University of Michigan with a B.S. in Mechanical Engineering and holds an M.S. from Stanford University. Additionally, she earned both an M.S. in Engineering and an MBA from the Massachusetts Institute of Technology.
Commitment to Innovation
Expressing her enthusiasm, Ms. Sahney stated, "I am extremely grateful to have been provided the opportunity to serve on Inogen’s board at such an exciting time in the company’s history. I look forward to helping Inogen continue to deliver value for shareholders and best-in-class solutions for patients." Her proactive approach and dedication to the field align with Inogen's mission to provide innovative solutions for respiratory care.
About Inogen
Inogen, Inc. (NASDAQ: INGN) is known for offering advanced respiratory products specifically designed for homecare settings. The company is committed to supporting patients by developing, manufacturing, and marketing high-quality respiratory therapy devices. By fostering partnerships with stakeholders, including patients, healthcare providers, and distributors, Inogen aims to enhance the quality of life for individuals facing chronic respiratory conditions.
Frequently Asked Questions
What recent changes have been made to Inogen's Board of Directors?
Inogen appointed Mira Kirti Sahney to its Board of Directors and announced the retirement of Tom West from the board.
When will Mira Sahney's appointment become effective?
Mira Sahney's appointment is effective on January 31, 2025.
What is Mira Sahney's background in the medical technology field?
Mira Sahney has extensive experience in medical devices, having held leadership roles at Medtronic, Hyalex Orthopaedics, and Smith + Nephew.
What notable contributions did Tom West make during his tenure?
Tom West played a significant role in Inogen's transformation over the past two years, making valuable contributions to the board.
How does Inogen plan to continue its innovation in respiratory care?
Inogen remains committed to developing and marketing innovative respiratory therapy devices, enhancing partnerships to provide better solutions for patients.
